Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 2.5601
-1.91 %
$ 3.43 M
Market Cap
-2.59
P/E
CASH FLOW STATEMENT
-2.4 M
OPERATING CASH FLOW
-2 K
INVESTING CASH FLOW
1.68 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sonoma Pharmaceuticals, Inc.
| Net Income | -4.84 M |
| Depreciation & Amortization | 176 K |
| Capital Expenditures | -17 K |
| Stock-Based Compensation | 516 K |
| Change in Working Capital | 1.69 M |
| Others | 2.18 M |
| Free Cash Flow | -2.42 M |
Cash Flow
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 | Mar-2005 | Mar-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||
| Net Income | (4.8) | (5.2) | (5.1) | (4.0) | (2.9) | (11.8) | (14.3) | 9.3 | (10.2) | (8.2) | 3.7 | (5.4) | (7.3) | (7.9) | (8.2) | (17.7) | (20.3) | (19.8) | (21.1) | (16.5) | (7.3) |
| Depreciation & Amortization | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.5 | 0.5 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.8 | 0.7 | 0.7 | 0.7 | 0.4 | 0.2 |
| Deferred Income Tax | (0.1) | 37 K | (0.8) | (1.4) | (1.2) | 0 | 0.7 | (4.3) | 0 | 0 | (10.9) | 1.0 | 7.4 | 0.2 | 72 K | 0.3 | 0 | (1.6) | 0 | 0 | 0 |
| Stock Based Compensation | 0.5 | 0.7 | 0.4 | 0.4 | 0.8 | 1.6 | 2.4 | 2.1 | 2.3 | 1.8 | 1.5 | 1.6 | 2.8 | 2.4 | 1.4 | 2.3 | 0 | 1.6 | 0 | 0 | 0 |
| Other Operating Activities | 0.2 | 0.1 | (2.0) | 4 K | 0.5 | (0.7) | 90 K | (15.3) | 0.5 | 1.7 | 0.9 | 0.6 | (7.1) | 0.1 | 0.4 | 0.4 | (0.4) | 1.7 | 87 K | 2.5 | 0.4 |
| Change in Working Capital | 1.7 | (1.9) | 3.1 | 1.4 | (2.0) | (1.3) | (1.8) | (0.3) | (1.7) | (2.2) | (0.3) | 3.1 | 83 K | 0.5 | (0.7) | (2.9) | 2.6 | (0.7) | 34 K | 81 K | 1.1 |
| Cash From Operations | (2.4) | (6.2) | (4.2) | (3.4) | (4.6) | (11.7) | (12.4) | (8.2) | (8.7) | (6.7) | (4.9) | 1.1 | (4.0) | (4.4) | (6.6) | (16.8) | (17.4) | (18.1) | (20.5) | (13.5) | (5.6) |
| INVESTING CASH FLOW | |||||||||||||||||||||
| Capital Expenditures | 17 K | (0.3) | (0.1) | (0.2) | (0.2) | 100 K | (0.2) | (0.4) | (0.3) | (0.1) | (0.5) | (0.3) | (0.3) | (0.2) | (0.1) | (0.4) | (0.6) | (0.9) | (0.5) | (1.0) | (1.0) |
| Other Items | 15 K | 11 K | 38 K | 0.6 | 3.9 | 31 K | 14 K | 18.6 | 4.5 | 1.0 | 59 K | (0.1) | 24 K | 10 K | 43 K | 31 K | 0 | 4 K | (1.1) | 76 K | 30 K |
| Cash From Investing Activities | 2 K | (0.3) | 99 K | 0.4 | 3.6 | (0.1) | (0.2) | 18.2 | 4.2 | 0.9 | (0.4) | (0.4) | (0.4) | (0.2) | (0.2) | (0.4) | (0.6) | (0.9) | (1.6) | (1.1) | (1.0) |
| FINANCING CASH FLOW | |||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.8 |
| Total Debt Repaid | (0.5) | (0.1) | (0.5) | 1.0 | (0.3) | (0.5) | (0.3) | (0.1) | (0.1) | (0.2) | (1.6) | (2.1) | 1.3 | 2.6 | (0.3) | (2.1) | (4.1) | 5.3 | (0.7) | 0.5 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.4 | 2.6 | 7.9 | 0 | 1.4 | 0 | 52 K | 98 K | 14 K | 0 | 1.4 | 0.9 | 0.2 | 0 | 0 | 0 | 0 | 0.4 | (0.5) | 0 | 7.3 |
| Cash From Financing Activities | 1.7 | 2.5 | 7.4 | 3.3 | 1.0 | 5.5 | 5.2 | 32 K | 6.0 | 6.6 | 2.9 | 3.8 | 3.4 | 2.7 | 11.1 | 0.4 | 17.8 | 30.6 | 26.1 | 17.2 | 7.3 |
| CHANGE IN CASH | |||||||||||||||||||||
| Net Change In Cash | (0.7) | (3.6) | 3.2 | 0.5 | 2 K | (6.4) | (7.4) | 10.0 | 1.3 | 0.7 | (2.4) | 4.5 | (1.0) | (1.9) | 4.3 | (16.9) | (0.2) | 11.6 | 4.2 | 2.4 | 0.7 |
| FREE CASH FLOW | |||||||||||||||||||||
| Free Cash Flow | (2.4) | (6.4) | (4.4) | (3.6) | (4.8) | (11.8) | (12.6) | (8.6) | (9.1) | (6.8) | (5.4) | 0.9 | (4.4) | (4.6) | (6.8) | (17.2) | (18.1) | (19.0) | (21.0) | (14.6) | (6.5) |